Nocebo – the evil twin that makes you feel worse

The placebo effect is well known in healthcare, but not so its opposite: nocebo. “The effect is small, but it can have major repercussions,” says Uppsala resear...

Join us at SLAS Barcelona

Festo LifeTech is exhibiting at the SLAS in Barcelona.

Introducing ZEISS arivis Pro 4.2

ZEISS arivis software enhances custom microscopy image analysis.

Come see us at the upcoming events!

We have some upcoming events where you can see our latest products live!

Ancient DNA provides new insights – “The immune system lost its job”

Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a...

A growing industry in Denmark: “One new life science company a week”

The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage...

Lista: Här är biotechbolagen som startade i Sverige förra året

Tuffa ekonomiska tider och försiktiga investerare drabbar små biotechbolag. Trots detta finns det företagare som vågar satsa och starta nytt. Life Science Swede...

Vinnova is going to establish a new innovation cluster

Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.

Just four weeks to a concept for an emergency ventilator

The lockdown in spring 2020 meant that the majority of Festo employees had to join the ranks of those working from home. Yet within the space of just four weeks...

Stopp för subventionerad botox vid skönhetsingrepp

Läkemedel med botulinumtoxin A – den aktiva substansen i botox – ska inte subventioneras längre när de används för estetisk injektionsbehandling.

Sobis läkemedel för blödarsjuka får grönt ljus i EU

Det svenska särläkemedelsbolaget Sobi har fått ett positivt omdöme i EU för sin nya behandling mot hemofili A. I ett utlåtande från den europeiska läkemedelsmyn...

Pfizer’s Paxlovid is being tested against post-COVID in a major Swedish study

In a new study conducted at the Karolinska University Hospital, Pfizer’s COVID drug, Paxlovid, is now being tested in patients with post-COVID. The study is one...

NorthX Biologics Matfors AB

Assignment: Facilitate the retention of foreign researchers

A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.

Sahlgrenska Science Park

Pharma Relations AB

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease

According to a new study, a combination of a cancer vaccine from Norwegian company Ultimovacs and two immunotherapies significantly prolonged survival in cases ...

The life science strategy – what the industry wants

The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...

Ready-to-install solutions for the lab-on-a-chip

Design for manufacturing lab-on-a-chip devices Reducing time-to-market together

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

Scientific Solutions

Meribel Pharma Solna

Anna Törner: Kalashnikovs in a new guise

Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...